024 Pharma, Inc. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5290a817-dcf7-4145-b738-db7b8ec1fec2/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2016 | $1.1M | 2016-01-01 – 2016-12-31 | evidence 0001683168-17-000653 |
| FY 2011 | $266.3k | 2011-01-01 – 2011-12-31 | evidence 0001185185-12-000527 |
| FY 2010 | $177.2k | 2010-01-01 – 2010-12-31 | evidence 0001185185-12-000527 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).